Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. - Wikidata - wikimedia - TriplyDB

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

http://www.wikidata.org/entity/Q38090691

about

Current and emerging treatment options for patients with relapsed myeloma The role of SLAMF7 in multiple myeloma: impact on therapy.Profile of elotuzumab and its potential in the treatment of multiple myeloma Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy.A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.Targeting Human β-Microglobulin with Monoclonal Antibodies in Multiple Myeloma - A Potential in Treatment.Choosing treatment options for patients with relapsed/refractory multiple myeloma.RNA interference for multiple myeloma therapy: targeting signal transduction pathways.Emerging antibodies for the treatment of multiple myeloma.Efficacy and safety of elotuzumab for the treatment of multiple myeloma.Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression Standardisation of minimal residual disease in multiple myeloma.Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.Antibody based immunotherapy for multiple myeloma: it's about time.

P2860

Q26830878-47B2D090-009E-4579-877A-D2C542A80625 Q30249167-972E9AB2-5532-45C8-91A2-DEE757714890 Q35628678-FB4A5207-A618-431B-A5F3-F53F710A950C Q35832168-686DF091-36CC-46B4-B3E9-4F5D933C20E0 Q36070261-AE67EFD5-9F0E-420D-8651-57C98090CB77 Q37138590-139E879F-A42F-4020-964F-6BCB83D97D15 Q38170453-16876419-BC07-4F7B-8C43-0BE5EFFD150E Q38550480-982B4493-DE72-4453-9A07-0D4493B48052 Q38838239-D31CAB40-8C68-43D5-B76C-CB6DC8F0CA32 Q39070515-3E583346-9C57-45ED-9F3D-156EEF80562E Q39136762-E32B7616-18DF-430D-8D5C-BF26801D9E88 Q39410899-4F9511AA-AB82-49A6-BDD9-FC2EBBCDECD4 Q45756098-BA728DEE-4614-4C47-841D-859C8E98FBCC Q53349911-F61131E0-0A57-401E-A74B-7D4A70A1D870

P2860

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

http://www.wikidata.org/entity/Q38090691

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

@en

type

label

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

@en

prefLabel

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

@en

P1433

Q38090691-A4DE5538-9006-4E88-9E69-FD52FE3FEE14

P1476

Q38090691-3CE0818D-4221-482A-B406-A9E821047E8F

P2093

Q38090691-3788944A-3F83-467D-A57E-487FFCA9F0F6

Q38090691-58901009-DA5F-4704-A356-9D52E4E5A070

Q38090691-6D911770-16FB-4DE4-9313-9BA0BB2712E9

Q38090691-876F918D-0328-4FC8-A3C1-311C1FDF9B28

Q38090691-9E394DA4-1DE7-4A25-B0FB-6EAD482EB851

Q38090691-DD4F024B-C2C9-44AC-8E9D-F8CDAE0C3007

Q38090691-DD5710EC-99EF-4AE0-9ACF-7586A4C699CC

P2860

Q38090691-005B3599-8BA6-4214-B167-BE1063F8571F

Q38090691-005F85CA-31B1-48A0-AFAB-7BA9128A11AF

Q38090691-007D8991-36BF-4569-8143-7706363524E4

Q38090691-05F2380B-F0D3-44F8-B0E6-7E90862B4CCA

Q38090691-061DF2A4-5F62-45AA-9018-A209715DF7EC

Q38090691-069AF622-EEEC-4967-9C59-686A4459C6B8

Q38090691-07AD3FD0-46EA-4AA6-81F2-381668A6D2F9

Q38090691-0EC7D881-A883-43B8-AB28-79FA499323F0

Q38090691-1089CCDC-2396-4CB4-A312-CA1B994F421A

Q38090691-12C62488-06C6-4070-A1FE-742F6F9A8A58

P304

Q38090691-F5CB6E14-7968-4731-8B50-867492D38ACF

P31

Q38090691-3CA1635C-8623-4BF7-BAE6-92DD83FBA624

P356

Q38090691-D765B28E-1492-4202-BD89-73F659AC340C

P433

Q38090691-60AC33A2-0997-48CA-980D-003B547AB4BC

P478

Q38090691-7DE00F58-6661-41BD-A64C-DEE8FF479411

P50

Q38090691-EE4EF3F8-A05A-4D0F-B540-B0E70FDEDB1B

P577

Q38090691-5D0688B9-C415-40D4-9169-D7041EB1D9FA

P5875

Q38090691-08A15D79-8D42-41F3-8CAA-63AFA09D347B

P698

Q38090691-C3DF2D2F-F86D-415F-B23D-6E81F77A8961

P356

P1433

European Journal of Haematology

P1476

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

@en

P2093

Andrea Alonci

http://www.w3.org/2001/XMLSchema#string

Bruna Greve

http://www.w3.org/2001/XMLSchema#string

Caterina Musolino

http://www.w3.org/2001/XMLSchema#string

Giuseppa Penna

http://www.w3.org/2001/XMLSchema#string

Sabina Russo

http://www.w3.org/2001/XMLSchema#string

Vanessa Innao

http://www.w3.org/2001/XMLSchema#string

Viviana Minardi

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence analysis identifies TTRAP, a protein that associates with CD40 and TNF receptor-associated factors, as a member of a superfamily of divalent cation-dependent phosphodiesterases

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Characterization of clonogenic multiple myeloma cells

Initial genome sequencing and analysis of multiple myeloma

A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.

Human CD38: a (r)evolutionary story of enzymes and receptors

DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation

P304

441-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12107

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Allegra

P577

2013-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236058699

http://www.w3.org/2001/XMLSchema#string

P698

23506222

http://www.w3.org/2001/XMLSchema#string